Advertisement

Diabetesformen bei Kindern und Jugendlichen

  • Olga KordonouriEmail author
  • Klemens Raile
Chapter
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Diabetes mellitus ist eine Stoffwechselerkrankung charakterisiert durch eine chronische Hyperglykämie als Resultat einer fehlenden Insulinsekretion, einer gestörten Insulinwirkung oder von beidem. Eine eindeutige Zuordnung der Diabetesform ist für Betroffene von hoher prognostischer und therapeutischer Relevanz.

Literatur

  1. Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384–389PubMedCrossRefPubMedCentralGoogle Scholar
  2. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG (2005) Natural history of type 1 diabetes. Diabetes 54(2):25–31CrossRefGoogle Scholar
  3. Aguilar-Bryan L, Bryan J (2008) Neonatal diabetes mellitus. Endocr Rev 29:265–291PubMedPubMedCentralCrossRefGoogle Scholar
  4. American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Diabetes Care 23:381–389CrossRefGoogle Scholar
  5. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81–S90CrossRefGoogle Scholar
  6. American Diabetes Association (2018) Classification and diagnosis of diabetes: standards of medical care in diabetes 2018. Diabetes Care 41(Suppl 1):S13–S27CrossRefGoogle Scholar
  7. Bastra MR, Aanstoot HJ, Herbrink P (2001) Prediction and diagnosis of type 1 diabetes using b-cell autoantibodies. Clin Lab 47:497–507Google Scholar
  8. Becker M, Galler A, Raile K (2014) Meglitinide analogues in adolescent patients with HNF1A-MODY (MODY 3). Pediatrics 133(3):e775–e779PubMedCrossRefPubMedCentralGoogle Scholar
  9. Bennett ST, Wilson AJ, Esposito L, Bouzekri N, Undlien DE, Cucca F, Nisticò L, Buzzetti R, Bosi E, Pociot F, Nerup J, Cambon-Thomsen A, Pugliese A, Shield JP, McKinney PA, Bain SC, Polychronakos C, Todd JA (1997) Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nat Genet 17:350–352PubMedCrossRefGoogle Scholar
  10. Charpentier N, Hartmann R, Deiss D, Danne T, Kordonouri O (2008) Prävalenz und Bedeutung der diabetes-spezifischen Autoantikörper GADA, IA-2A und IAA zum Zeitpunkt der Manifestation eines Typ-1 Diabetes bei 341 Kindern und Jugendlichen. Diabetol Stoffw 3:159–165CrossRefGoogle Scholar
  11. Davis EJ, Kahoska AR, Jefferies C, Dabelea D, Balde N, Ashner P, Craig ME (2018) Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 19(Suppl 27):7–19PubMedCrossRefGoogle Scholar
  12. Drachenberg CB, Klassen DK, Weir MR et al (1999) Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68:396–402PubMedCrossRefGoogle Scholar
  13. Edghill EL, Flanagan SE, Patch AM et al (2008) Insulin mutation screening in 1044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57:1034–1042PubMedCrossRefGoogle Scholar
  14. Ellard S, Bellanné-Chantelot C, Hattersley AT, European Molecular Genetics Quality Network (EMQN) MODY Group (2008) Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51:546–553PubMedPubMedCentralCrossRefGoogle Scholar
  15. Fajans SS, Bell GI, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980PubMedCrossRefGoogle Scholar
  16. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT (2006) Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 49:1190–1197PubMedCrossRefGoogle Scholar
  17. Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. CMAJ 175:165–170PubMedPubMedCentralCrossRefGoogle Scholar
  18. Gloyn AL, Diatloff-Zito C, Edghill EL et al (2006) KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 14:824–830PubMedCrossRefPubMedCentralGoogle Scholar
  19. Grulich-Henn J, Wagner V, Thon A, Schober E, Marg W, Kapellen TM, Haberland H, Raile K, Ellard S, Flanagan SE et al (2010) Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med J Br Diabetic Assoc 27(6):709–712CrossRefGoogle Scholar
  20. Haldorsen IS, Vesterhus M, Raeder H, Jensen DK, Sovik O, Molven A, Njolstad PR (2008) Lack of pancreatic body and tail in HNF1B mutation carriers. Diabet Med J Br Diabetic Assoc 25(7):782–787CrossRefGoogle Scholar
  21. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K, International Society for Pediatric and Adolescent Diabetes ISPAD Clinical Practice Consensus Guidelines 2006–2007 (2006) The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 7:352–360PubMedCrossRefPubMedCentralGoogle Scholar
  22. Herskowitz-Dumont R, Wolfsdorf JI, Jackson RA, Eisenbarth GS (1993) Distinction between transient hyperglycemia and early insulin-dependent diabetes mellitus in childhood: a prospective study of incidence and prognostic factors. J Pediatr 123:347–354PubMedCrossRefPubMedCentralGoogle Scholar
  23. Insel RA, Dunne JL, Atkinson MA et al (2015) Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38:1964–1974PubMedPubMedCentralCrossRefGoogle Scholar
  24. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334Google Scholar
  25. Koch C, Rainisio M, Madessani U et al (2001) Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 32:343–350PubMedCrossRefPubMedCentralGoogle Scholar
  26. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C (1994) Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 83:72–77PubMedCrossRefPubMedCentralGoogle Scholar
  27. Maes BD, Kuypers D, Messiaen T et al (2001) Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 72:1655–1661PubMedCrossRefPubMedCentralGoogle Scholar
  28. Moran A, Pilay K, Becker DJ, Granados A, Hameed S, Acerini CL (2018) Management of cystic fibrosis-related diabetes in children and adolescents. ISPAD Clinical Practice Consensus Guidelines 2018 Compedium. Pediatr Diabetes 19(suppl 27):64–74PubMedCrossRefPubMedCentralGoogle Scholar
  29. Neu A, Feldhahn L, Ehehalt S, Hub R, Ranke MB, DIARY group Baden-Württemberg. (2009) Type 2 diabetes mellitus in children and adolescents is still a rare disease in Germany: a population-based assessment of the prevalence of type 2 diabetes and MODY in patients aged 0–20 years. Pediatr Diabetes 10(7):468–473Google Scholar
  30. Noble JA, Erlich HA (2012) Genetics of type 1 diabetes. Cold Spring Harb Perspect Med 2(1):a007732PubMedPubMedCentralCrossRefGoogle Scholar
  31. O’Riordan SM, Robinson PD, Donaghue KC, Moran A (2008) Management of cystic fibrosis-related diabetes. Pediatr Diabetes 9:338–344PubMedCrossRefGoogle Scholar
  32. Owen K, Hattersley AT (2001) Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 15:309–323PubMedCrossRefGoogle Scholar
  33. Pearson ER, Flechtner I, Njolstad PR et al (2006) Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467–477PubMedCrossRefGoogle Scholar
  34. Pihoker C, Gilliam LK, Ellard S, Dabelea D, Davis C, Dolan LM, Greenbaum CJ, Imperatore G, Lawrence JM, Marcovina SM et al (2013) Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab 98(10):4055–4062PubMedPubMedCentralCrossRefGoogle Scholar
  35. Pui CH, Burghen GA, Bowman WP, Aur RJ (1981) Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr 99:46–50PubMedCrossRefGoogle Scholar
  36. Raeder H, Johansson S, Holm PI et al (2006) Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet 38:54–62PubMedPubMedCentralCrossRefGoogle Scholar
  37. Raile K, Schober E, Konrad K, Thon A, Grulich-Henn J, Meissner T, Wolfle J, Scheuing N, Holl RW, Mellitus DPVItGBCND (2015) Treatment of young patients with HNF1A mutations (HNF1A-MODY). Diabet Med J Br Diabetic Assoc 32(4):526–530CrossRefGoogle Scholar
  38. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376–1379PubMedCrossRefGoogle Scholar
  39. Rich SS, Onengut-Gumuscu S, Concannon P (2009) Recent progress in the genetics of diabetes. Horm Res 71(Suppl 1):17–23PubMedGoogle Scholar
  40. Schatz DA, Bingley PJ (2001) Update on major trials for the prevention of type 1 diabetes mellitus: the American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT). J Pediatr Endocrinol Metab 14(Suppl 1):619–622PubMedPubMedCentralGoogle Scholar
  41. Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW, DP-WIotGWGfPD (2009) Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabetic medicine : a journal of the British Diabetic Association. 26(5):466–473CrossRefGoogle Scholar
  42. Shehadeh N, On A, Kessel I et al (1997) Stress hyperglycemia and the risk for the development of type 1 diabetes. J Pediatr Endocrinol Metab 10:283–286PubMedCrossRefPubMedCentralGoogle Scholar
  43. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53(12):2504–2508PubMedCrossRefPubMedCentralGoogle Scholar
  44. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus (2014) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167CrossRefGoogle Scholar
  45. Valerio G, Franzese A, Carlin E, Pecile P, Perini R, Tenore A (2001) High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr 90:618–622PubMedCrossRefPubMedCentralGoogle Scholar
  46. WHO (World Health Organization), IDF (International Diabetes Federation) (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization, GenevaGoogle Scholar
  47. Yang Y, Chan L (2016) Monogenic diabetes: what it teaches us on the common forms of type 1 and type 2 diabetes. Endocr Rev 37(3):190–222PubMedPubMedCentralCrossRefGoogle Scholar
  48. Ziegler AG, Bonifacio E, Group BB S (2012) Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 55:1937–1943PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.Allgemeine Pädiatrie, Diabetologie, Endokrinologie und Klinische ForschungKinder- und Jugendkrankenhaus AUF DER BULTHannoverDeutschland
  2. 2.Klinik für Pädiatrie mit Schwerpunkt Pädiatrische Endokrinologie und DiabetologieCharité, Universitätsmedizin BerlinBerlinDeutschland

Section editors and affiliations

  • Thomas Danne
    • 1
  1. 1.Abteilung für Allgemeine Pädiatrie, Diabetologie, Endokrinologie und Klinische ForschungKinder- und Jugendkrankenhaus AUF DER BULTHannoverDeutschland

Personalised recommendations